Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biotechnology Index NYSE ETF (FBT)

Biotechnology Index NYSE ETF (FBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 1,911,250,000
  • Market Capitalization, $K 1,911,250
  • Shares Outstanding, K 12,500
  • 60-Month Beta 1.26
  • Price/Earnings ttm 24.10
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.020 on 09/23/15
  • Management Fee 0.55%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.50 +1.94%
on 09/11/20
161.12 -5.41%
on 08/31/20
-3.89 (-2.49%)
since 08/24/20
3-Month
149.50 +1.94%
on 09/11/20
180.64 -15.63%
on 07/20/20
-15.75 (-9.37%)
since 06/24/20
52-Week
108.08 +41.01%
on 03/18/20
180.64 -15.63%
on 07/20/20
+24.67 (+19.31%)
since 09/24/19

Most Recent Stories

More News
How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
ARKG : 60.12 (+0.08%)
Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

AZN : 54.17 (-2.68%)
IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
ARKG : 60.12 (+0.08%)
Red Hot ETF Areas Amid the Coronavirus Crisis

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
PNQI : 196.93 (-0.66%)
FBT : 152.40 (-0.27%)
ARKW : 103.00 (-0.14%)
FDN : 180.79 (-0.75%)
ESGU : 73.48 (+0.14%)
ESGV : 59.50 (+0.20%)
OGIG : 42.24 (-0.73%)
USSG : 29.61 (+0.20%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 62.25 (-1.33%)
LLY : 148.81 (-0.67%)
IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
ARKG : 60.12 (+0.08%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 144.67 (+0.16%)
AZN : 54.17 (-2.68%)
MRNA : 65.17 (-2.96%)
NVAX : 102.44 (+0.86%)
IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
ARKG : 60.12 (+0.08%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 3,019.79 (+0.66%)
GILD : 62.25 (-1.33%)
IBB : 130.69 (-1.05%)
BABA : 269.73 (-1.18%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
IBUY : 85.15 (-1.25%)
BOTZ : 26.78 (-0.19%)
SKYY : 75.36 (-0.66%)
CLIX : 82.26 (-0.37%)
ARKG : 60.12 (+0.08%)
ONLN : 60.44 (-0.61%)
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

GILD : 62.25 (-1.33%)
IBB : 130.69 (-1.05%)
CNCR : 26.24 (-1.98%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
PTH : 128.32 (-1.60%)
IHF : 190.16 (-0.15%)
IHE : 159.62 (-0.74%)
XPH : 42.46 (-1.99%)
SBIO : 39.70 (-1.32%)
XHS : 72.41 (+1.57%)
PBE : 54.93 (-0.74%)
IDNA : 38.14 (-1.29%)
Ride Out the Coronavirus Mayhem With These ETF Areas

We discuss some ETF areas that investors can choose to invest for a smoother sail during the coronavirus pandemic.

AMZN : 3,019.79 (+0.66%)
GILD : 62.25 (-1.33%)
IBB : 130.69 (-1.05%)
BABA : 269.73 (-1.18%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
IBUY : 85.15 (-1.25%)
BOTZ : 26.78 (-0.19%)
ROBO : 46.28 (-0.26%)
SKYY : 75.36 (-0.66%)
CLIX : 82.26 (-0.37%)
ARKG : 60.12 (+0.08%)
Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.

REGN : 557.46 (-1.37%)
PFE : 35.76 (-0.67%)
GILD : 62.25 (-1.33%)
MRNA : 65.17 (-2.96%)
ABT : 100.92 (-1.76%)
AMGN : 240.32 (-0.94%)
TMO : 418.14 (-0.62%)
IBB : 130.69 (-1.05%)
INO : 15.37 (-3.76%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)
ARKG : 60.12 (+0.08%)
IEIH : 29.38 (-0.85%)
BNTX : 62.83 (-1.57%)
ETFs to Rise as Gilead Drug Shows Promise in Coronavirus Cure

Gilead Sciences (GILD) has ignited a ray of hope with its recently-released positive data on the role of remdesivir as a COVID-19 treatment.

REGN : 557.46 (-1.37%)
SNY : 50.79 (+0.36%)
RHHBY : 44.7000 (-0.36%)
GILD : 62.25 (-1.33%)
INCY : 85.07 (-1.05%)
NVS : 86.30 (-1.32%)
AMGN : 240.32 (-0.94%)
IBB : 130.69 (-1.05%)
XBI : 108.07 (-0.99%)
BBH : 155.04 (+0.17%)
FBT : 152.40 (-0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade FBT with:

Fund Summary

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted...

See More

Key Turning Points

2nd Resistance Point 155.11
1st Resistance Point 153.75
Last Price 152.40
1st Support Level 150.31
2nd Support Level 148.23

See More

52-Week High 180.64
Fibonacci 61.8% 152.92
Last Price 152.40
Fibonacci 50% 144.36
Fibonacci 38.2% 135.80
52-Week Low 108.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar